Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1568476901
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4301 W Markham St, Slot 816
Little Rock, AR, 72205
Phone (501) 526-2873
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,013 services
Medicare patients, 2024
356
Average age 73
Drug cost, 2024
$12.3M
828 prescriptions
Company payments, 2025
$299
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maurizio Zangari was code 99215 (office e&m - established), 624 times for 334 patients. In total Maurizio Zangari billed 1,013 services in 8 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 624 | 334 | $100.20 | $63K |
| 99233 Hospital E&M - Subsequent | Facility | 176 | 48 | $82.73 | $15K |
| 99214 Office E&M - Established | Office | 79 | 75 | $69.96 | $5,527 |
| 99214 Office E&M - Established | Facility | 74 | 67 | $62.18 | $4,601 |
| 99205 Office E&M - New | Facility | 13 | 13 | $114.69 | $1,491 |
| 99213 Office E&M - Established | Facility | 12 | 12 | $43.72 | $525 |
| 99215 Office E&M - Established | Office | 11 | 11 | $98.17 | $1,080 |
By year: 2022 $95K for 1,101 services; 2023 $95K for 1,024 services; 2024 $91K for 1,013 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maurizio Zangari prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 261 prescriptions and refills. In total Maurizio Zangari wrote 828 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 261 | 261 | 55 | $4.5M |
| Lenalidomide Generic | 232 | 232 | 34 | $2.8M |
| Pomalyst Pomalidomide | 217 | 217 | 34 | $4.9M |
| Lorazepam Generic | 52 | 52 | 44 | $27.43 |
| Morphine Sulfate Generic | 43 | 43 | 33 | $17.8 |
Brand drugs: 534 claims; generic drugs: 294 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maurizio Zangari $299 ($299 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $160.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.